New diagnostic and therapeutic tools
against multidrug resistant tumours

Joint workshop of EpiLipidNET WG2 and Stratagem COST Action

Joint workshop of EpiLipidNET WG2 and Stratagem COST Action
Multidrug resistant (MDR) solid tumour research meets lipidomics and epilipidomics research.
Members of two COST Actions: EpiLipidNET and Stratagem will participate in a joint online workshop on 18th October 2022, 3 pm CET.
The workshop intends to present the posibilities, stemming from the intersection of both research fields and to stimulate cooperation between researchers.

 

 

Time: Oct 18, 2022 03:00 PM Amsterdam, Berlin, Rome, Stockholm, Vienna
Join Zoom Meeting
link: https://tu-dresden.zoom.us/j/65100470825?pwd=d0tnQS9EOWM3dGNKR3NBNEZ0eEt1dz09
Meeting ID: 651 0047 0825
Passcode: pH=W0*i6

Agenda:

  • 3:00–3:15 Introduction on EpiLipidNET: Pan-European Network in Lipidomics and EpiLipidomics – Rosario Domingues (University of Aveiro, Portugal) and Maria Fedorova (TU Dresden, Germany)
  • 3:15 – 3:30 Introduction on STRATAGEM: New diagnostic and therapeutic tools against multidrug resistant tumours – Chiara Riganti (University of Turin, Italy)
  • 3:30 – 3:50 Drugs & Lipids: from therapies to lipid disorders induction – Laura Goracci (University of Perugia, Italy)
  • 3:50 – 4:10 Metabolite of the endocannabinoid precursor lipid N-arachidonoylphosphatidylethanolamine selectively inhibits mesenchymal tumor invasion of 3D spheroids Zsolt Balogi (University of Pécs, Hungary)
  • 4:10 – 4:30 Effects of lipid raft disruption on APQ3 and NRF2 – Ana Cipak Gasparovic (Ruđer Bošković Institute, Croatia)
  • 4:30 – 4:50 Microenvironment-mediated lipid metabolism reprogramming and anti-EGFR therapy resistance in squamous cell carcinoma of the head and neck – Valentin Van Den Bossche (Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), University of Louvain (UCL) Medical School, Cyril Corbet lab, Belgium)
  • 4:50 – 5:10 ECI meet the speakers (breakout rooms) & breakout room for free discussion
  • 5:10 Closing remarks

Brochure: [news post]

Back to Events / News